Across TCGA pan-cancer cohorts, WDR44 mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated WDR44 data layer compared with 21 for mass-spec protein and 6 for mutation status.
The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher WDR44 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated WDR44 expression acts as an unfavorable survival marker, although some lineages such as UCEC and HNSC show a favorable association.
CCRCC, UCEC, and LUAD are the cancer types where WDR44 mass-spec protein most reproducibly stratifies survival.